Literature DB >> 20106624

Detection of bone metastases using diffusion weighted magnetic resonance imaging: comparison with (11)C-methionine PET and bone scintigraphy.

Behnaz Goudarzi1, Riwa Kishimoto, Shuhei Komatsu, Hiroyuki Ishikawa, Kyosan Yoshikawa, Susumu Kandatsu, Takayuki Obata.   

Abstract

PURPOSE: We evaluated the ability of diffusion-weighted imaging (DWI) to detect bone metastasis by comparing the results obtained using this modality with those obtained using (11)C-methionine (MET) positron emission tomography (PET) and bone scintigraphy.
MATERIALS AND METHODS: This retrospective study involved 29 patients with bone metastasis. DWI was obtained using a single-shot echo planar imaging (EPI) sequence with fat suppression using a short inversion time inversion recovery sequence. The detection capabilities of DWI for bone metastases were compared with those of whole body MET PET (in 19 patients) and 99mTc-methylene diphosphonate bone scintigraphy (in 15 patients).
RESULTS: Among the 19 patients who were diagnosed using DWI and PET, the PET identified 39 bone metastases, while the DWI identified 60 metastases out of 69 metastases revealed with conventional magnetic resonance imaging (MRI). Among the 15 patients who were diagnosed using DWI and bone scintigraphy, the bone scintigraphy identified 18 bone metastases, while the DWI identified 72 metastases out of 78 metastases revealed with conventional MRI. The overall bone metastasis detection rates were 56.5% for PET, 23.1% for bone scintigraphy and 92.3% for DWI.
CONCLUSION: DWI is a very sensitive method for detecting bone metastasis and is superior to MET PET and bone scintigraphy in terms of its detection capabilities. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106624     DOI: 10.1016/j.mri.2009.12.008

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  11 in total

Review 1.  Diffusion-weighted imaging in musculoskeletal radiology-clinical applications and future directions.

Authors:  Nicholas Bhojwani; Peter Szpakowski; Sasan Partovi; Martin H Maurer; Ulrich Grosse; Hendrik von Tengg-Kobligk; Lisa Zipp-Partovi; Nathan Fergus; Christos Kosmas; Konstantin Nikolaou; Mark R Robbin
Journal:  Quant Imaging Med Surg       Date:  2015-10

2.  Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility.

Authors:  C Messiou; D J Collins; V A Morgan; N M Desouza
Journal:  Eur Radiol       Date:  2011-04-07       Impact factor: 5.315

3.  Molecular and functional imaging of invasion and metastasis: windows into the metastatic cascade.

Authors:  Ioannis Stasinopoulos; Marie-France Penet; Balaji Krishnamachary; Zaver M Bhujwalla
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

4.  Complementary roles of tumour specific PET tracer ¹⁸F-FAMT to ¹⁸F-FDG PET/CT for the assessment of bone metastasis.

Authors:  Motoho Morita; Tetsuya Higuchi; Arifudin Achmad; Azusa Tokue; Yukiko Arisaka; Yoshito Tsushima
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-05       Impact factor: 9.236

Review 5.  MRI of metastasis-permissive microenvironments.

Authors:  Marie-France Penet; Zhihang Chen; Zaver M Bhujwalla
Journal:  Future Oncol       Date:  2011-11       Impact factor: 3.404

6.  Comparative Study between 18F FDG-PET/CT and Whole Body MRI DWIBS in Assessment of Recurrent Breast Cancer (Prospective, Comparative, Cross-sectional Study Design).

Authors:  Mahmoud Rezk; Ibrahim Nasr; Ismail Ali; Heba Abdelhamed
Journal:  Indian J Nucl Med       Date:  2019 Jan-Mar

Review 7.  Therapy response with diffusion MRI: an update.

Authors:  Lauren J Bains; Martin Zweifel; Harriet C Thoeny
Journal:  Cancer Imaging       Date:  2012-09-28       Impact factor: 3.909

Review 8.  Bony metastases: assessing response to therapy with whole-body diffusion MRI.

Authors:  A R Padhani; A Gogbashian
Journal:  Cancer Imaging       Date:  2011-10-03       Impact factor: 3.909

9.  Diffusion-weighted Magnetic Resonance Imaging in the Diagnosis of Bone Tumors: Preliminary Results.

Authors:  Yeliz Pekcevik; Mehmet Onur Kahya; Ahmet Kaya
Journal:  J Clin Imaging Sci       Date:  2013-12-31

Review 10.  DCE-MRI, DW-MRI, and MRS in Cancer: Challenges and Advantages of Implementing Qualitative and Quantitative Multi-parametric Imaging in the Clinic.

Authors:  Jessica M Winfield; Geoffrey S Payne; Alex Weller; Nandita M deSouza
Journal:  Top Magn Reson Imaging       Date:  2016-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.